rs71664954

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001854.4(COL11A1):​c.1944+11T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0277 in 1,602,428 control chromosomes in the GnomAD database, including 783 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.024 ( 62 hom., cov: 32)
Exomes 𝑓: 0.028 ( 721 hom. )

Consequence

COL11A1
NM_001854.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.414
Variant links:
Genes affected
COL11A1 (HGNC:2186): (collagen type XI alpha 1 chain) This gene encodes one of the two alpha chains of type XI collagen, a minor fibrillar collagen. Type XI collagen is a heterotrimer but the third alpha chain is a post-translationally modified alpha 1 type II chain. Mutations in this gene are associated with type II Stickler syndrome and with Marshall syndrome. A single-nucleotide polymorphism in this gene is also associated with susceptibility to lumbar disc herniation. Multiple transcript variants have been identified for this gene. [provided by RefSeq, Nov 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 1-103004433-A-G is Benign according to our data. Variant chr1-103004433-A-G is described in ClinVar as [Benign]. Clinvar id is 195479.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-103004433-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0607 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
COL11A1NM_001854.4 linkuse as main transcriptc.1944+11T>C intron_variant ENST00000370096.9 NP_001845.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
COL11A1ENST00000370096.9 linkuse as main transcriptc.1944+11T>C intron_variant 1 NM_001854.4 ENSP00000359114 P1P12107-1

Frequencies

GnomAD3 genomes
AF:
0.0241
AC:
3660
AN:
152118
Hom.:
62
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0142
Gnomad AMI
AF:
0.00330
Gnomad AMR
AF:
0.0273
Gnomad ASJ
AF:
0.0424
Gnomad EAS
AF:
0.0664
Gnomad SAS
AF:
0.0534
Gnomad FIN
AF:
0.00273
Gnomad MID
AF:
0.0918
Gnomad NFE
AF:
0.0262
Gnomad OTH
AF:
0.0287
GnomAD3 exomes
AF:
0.0299
AC:
7464
AN:
249280
Hom.:
168
AF XY:
0.0321
AC XY:
4334
AN XY:
134894
show subpopulations
Gnomad AFR exome
AF:
0.0128
Gnomad AMR exome
AF:
0.0157
Gnomad ASJ exome
AF:
0.0435
Gnomad EAS exome
AF:
0.0746
Gnomad SAS exome
AF:
0.0493
Gnomad FIN exome
AF:
0.00315
Gnomad NFE exome
AF:
0.0283
Gnomad OTH exome
AF:
0.0283
GnomAD4 exome
AF:
0.0281
AC:
40759
AN:
1450192
Hom.:
721
Cov.:
29
AF XY:
0.0290
AC XY:
20909
AN XY:
721976
show subpopulations
Gnomad4 AFR exome
AF:
0.0142
Gnomad4 AMR exome
AF:
0.0165
Gnomad4 ASJ exome
AF:
0.0429
Gnomad4 EAS exome
AF:
0.0592
Gnomad4 SAS exome
AF:
0.0490
Gnomad4 FIN exome
AF:
0.00420
Gnomad4 NFE exome
AF:
0.0269
Gnomad4 OTH exome
AF:
0.0296
GnomAD4 genome
AF:
0.0241
AC:
3672
AN:
152236
Hom.:
62
Cov.:
32
AF XY:
0.0240
AC XY:
1785
AN XY:
74432
show subpopulations
Gnomad4 AFR
AF:
0.0145
Gnomad4 AMR
AF:
0.0272
Gnomad4 ASJ
AF:
0.0424
Gnomad4 EAS
AF:
0.0665
Gnomad4 SAS
AF:
0.0536
Gnomad4 FIN
AF:
0.00273
Gnomad4 NFE
AF:
0.0262
Gnomad4 OTH
AF:
0.0289
Alfa
AF:
0.0268
Hom.:
17
Bravo
AF:
0.0251
Asia WGS
AF:
0.0440
AC:
151
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Benign, criteria provided, single submitterclinical testingGeneDxOct 05, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Nov 15, 2014- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical Center-- -
not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Fibrochondrogenesis 1 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Stickler syndrome type 2 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.64
CADD
Benign
11
DANN
Benign
0.85

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs71664954; hg19: chr1-103469989; API